The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) each follow structured processes to assess these data and develop rigorous, evidence-based guidelines for adults with diabetes and CKD.1,2 Areas of consensus between the 2 guidelines therefore represent ...
Journey Biosciences, a biotechnology innovator of predictive screenings for diabetes-related complications, today announced that a dedicated CPT PLA code, 0384U, has been assigned for its flagship product, NaviDKD, by the American Medical ...
Metformin in People With Diabetes and Advanced CKD: Should We Dare? Jung-Im Shin, Antoine Créon, Juan-Jesus CarreroIn Press, Corrected Proof, Available online 10 December 2024 View PDF select article Acute Kidney Injury in Care Transitions (ACT): A Randomized Controlled Feasibility Trial Correspon...
American Diabetes Association Highlights Novel Agent Retatrutide which Results in Substantial Weight Reduction in People with Obesity or Type 2 Diabetes During Late Breaking SymposiumJune 26, 2023 | 7 min read...
Summary of KDIGO and American Diabetes Association (ADA) recommendations regarding surveillance among acute kidney injury, chronic kidney disease, and diabetic patient cohorts.Michael, E. MathenyJosh, F. PetersonSvetlana, K. E...
Additionally, the positive association between the conicity index and all-cause mortality is notably stronger among those without diagnosed hypertension or diabetes. Kidney stones, an increasingly serious public health issue, continue to impose a growing burden on healthcare systems. Therefore, identifying...
The American Diabetes Association (ADA) updates its Standards of Medical Care (SOMC) in Diabetes annually. These ADA standards make up a comprehensive document that serves as an excellent resource for clinical care. The current article comes from the ADA
Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hy... Moreover, it has been determined that increased left ventricular mass, which is an independent risk factor for cardiovascular disease in adults,...
(hHF), cardiovascular death or chronic kidney disease (CKD) progression should be considered independently of baseline HbA 1c or individualised HbA 1c target; (2) GLP-1 receptor agonists can also be considered in patients with type 2 diabetes without established cardiovascular disease (CVD) but ...
the readability of type 2 diabetes online patient education materials from academic institutions in the northeast USA and the American Diabetes Association. Man... Brenda,Dorcely,Nitin,... - 《Health Education Journal》 被引量: 1发表: 2015年 Heart Disease and Stroke Statistics-2016 Update: A Re...